These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 12778843)
1. Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study. Fava M; Rush AJ; Trivedi MH; Nierenberg AA; Thase ME; Sackeim HA; Quitkin FM; Wisniewski S; Lavori PW; Rosenbaum JF; Kupfer DJ Psychiatr Clin North Am; 2003 Jun; 26(2):457-94, x. PubMed ID: 12778843 [TBL] [Abstract][Full Text] [Related]
2. The sequenced treatment alternatives to relieve depression (STAR*D) trial: a review. Sinyor M; Schaffer A; Levitt A Can J Psychiatry; 2010 Mar; 55(3):126-35. PubMed ID: 20370962 [TBL] [Abstract][Full Text] [Related]
3. Enrolling research subjects from clinical practice: ethical and procedural issues in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial. Alpert JE; Biggs MM; Davis L; Shores-Wilson K; Harlan WR; Schneider GW; Ford AL; Farabaugh A; Stegman D; Ritz AL; Husain MM; Macleod L; Wisniewski SR; Rush AJ; Psychiatry Res; 2006 Feb; 141(2):193-200. PubMed ID: 16457894 [TBL] [Abstract][Full Text] [Related]
4. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Rush AJ; Trivedi MH; Wisniewski SR; Nierenberg AA; Stewart JW; Warden D; Niederehe G; Thase ME; Lavori PW; Lebowitz BD; McGrath PJ; Rosenbaum JF; Sackeim HA; Kupfer DJ; Luther J; Fava M Am J Psychiatry; 2006 Nov; 163(11):1905-17. PubMed ID: 17074942 [TBL] [Abstract][Full Text] [Related]
5. Switching to sertraline or venlafaxine after failure of SSRIs treatment in major depressive disorder: an economic evaluation of the STAR*D trial. Leelahanaj T J Med Assoc Thai; 2012 May; 95 Suppl 5():S29-37. PubMed ID: 22934442 [TBL] [Abstract][Full Text] [Related]
6. The STAR*D Trial: It Is Time to Reexamine the Clinical Beliefs That Guide the Treatment of Major Depression. Pigott HE Can J Psychiatry; 2015 Jan; 60(1):9-13. PubMed ID: 25886544 [No Abstract] [Full Text] [Related]
7. Modelling the cost-effectiveness of pharmacotherapy compared with cognitive-behavioural therapy and combination therapy for the treatment of moderate to severe depression in the UK. Koeser L; Donisi V; Goldberg DP; McCrone P Psychol Med; 2015 Oct; 45(14):3019-31. PubMed ID: 26040631 [TBL] [Abstract][Full Text] [Related]
8. STAR*D: have we learned the right lessons? Keitner GI; Solomon DA; Ryan CE Am J Psychiatry; 2008 Jan; 165(1):133; author reply 133-4. PubMed ID: 18178755 [No Abstract] [Full Text] [Related]
9. Effectiveness of cognitive-behavioural therapy plus pharmacotherapy in inpatient treatment of depressive disorders. Köhler S; Hoffmann S; Unger T; Steinacher B; Dierstein N; Fydrich T Clin Psychol Psychother; 2013; 20(2):97-106. PubMed ID: 22095701 [TBL] [Abstract][Full Text] [Related]
10. Sequenced Treatment Alternatives to Relieve Depression (STAR*D). Part 2: Study outcomes. Howland RH J Psychosoc Nurs Ment Health Serv; 2008 Oct; 46(10):21-4. PubMed ID: 18935932 [TBL] [Abstract][Full Text] [Related]
11. [Should the treatment of depression in the Netherlands be changed after the STAR*D study?]. Paalvast Y; Nolen WA Tijdschr Psychiatr; 2008; 50(4):223-8. PubMed ID: 18398802 [TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of active monitoring versus antidepressants for major depression in primary health care: a 12-month non-randomized controlled trial (INFAP study). Rubio-Valera M; Beneitez I; Peñarrubia-María MT; Luciano JV; Mendive JM; McCrone P; Knapp M; Sabés-Figuera R; Kocyan K; García-Campayo J; Serrano-Blanco A BMC Psychiatry; 2015 Mar; 15():63. PubMed ID: 25885818 [TBL] [Abstract][Full Text] [Related]
13. Navigating the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study: practical outcomes and implications for depression treatment in primary care. Cain RA Prim Care; 2007 Sep; 34(3):505-19, vi. PubMed ID: 17868757 [TBL] [Abstract][Full Text] [Related]
14. Clinical features and drug induced side effects in early versus late antidepressant responders. Fabbri C; Marsano A; Balestri M; De Ronchi D; Serretti A J Psychiatr Res; 2013 Oct; 47(10):1309-18. PubMed ID: 23800418 [TBL] [Abstract][Full Text] [Related]
15. Treatment strategies to improve and sustain remission in major depressive disorder. Trivedi MH; Daly EJ Dialogues Clin Neurosci; 2008; 10(4):377-84. PubMed ID: 19170395 [TBL] [Abstract][Full Text] [Related]
16. Children of depressed mothers 1 year after the initiation of maternal treatment: findings from the STAR*D-Child Study. Pilowsky DJ; Wickramaratne P; Talati A; Tang M; Hughes CW; Garber J; Malloy E; King C; Cerda G; Sood AB; Alpert JE; Trivedi MH; Fava M; Rush AJ; Wisniewski S; Weissman MM Am J Psychiatry; 2008 Sep; 165(9):1136-47. PubMed ID: 18558646 [TBL] [Abstract][Full Text] [Related]
17. Changes in depressive symptoms and social functioning in the sequenced treatment alternatives to relieve depression study. Denninger JW; van Nieuwenhuizen AO; Wisniewski SR; Luther JF; Trivedi MH; Rush AJ; Gollan JK; Pizzagalli DA; Fava M J Nerv Ment Dis; 2011 Oct; 199(10):807-10. PubMed ID: 21964277 [TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of usual general practitioner care with or without antidepressant medication for patients with minor or mild-major depression. Bosmans JE; Hermens ML; de Bruijne MC; van Hout HP; Terluin B; Bouter LM; Stalman WA; van Tulder MW J Affect Disord; 2008 Nov; 111(1):106-12. PubMed ID: 18342952 [TBL] [Abstract][Full Text] [Related]
19. The health value and cost of care for major depression. Watkins KE; Burnam MA; Orlando M; Escarce JJ; Huskamp HA; Goldman HH Value Health; 2009; 12(1):65-72. PubMed ID: 19911440 [TBL] [Abstract][Full Text] [Related]
20. Is It Time to Try Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Again? Perlis RH; Fava M JAMA Psychiatry; 2022 Apr; 79(4):281-282. PubMed ID: 35138341 [No Abstract] [Full Text] [Related] [Next] [New Search]